FDA Grants Priority Review to Merck’s New Biologics License Application for V116, an…
Merck, known as MSD outside of the United States and Canada, announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a new Biologics License Application…
Read More...
Read More...